Sam A. Eldessouky
Overview
Sam A. Eldessouky received an average of $3M in total compensation, including $560K in salary, at Valeant Pharmaceuticals International between 2020 and 2021.
Source: SEC filing on May 2, 2022.
Related executives
We found 27 more executives who work or worked at Valeant Pharmaceuticals International.
Joseph Papa
Valeant Pharmaceuticals International
Chief Executive Officer
Thomas Appio
Valeant Pharmaceuticals International
President Co, Head Bausch + Lomb/International
Paul Herendeen
Valeant Pharmaceuticals International
Chief Financial Officer
Christina Ackermann
Valeant Pharmaceuticals International
General Counsel
Robert Spurr
Valeant Pharmaceuticals International
President, U.S. Pharma Business
Joseph Gordon
Valeant Pharmaceuticals International
President & Co, Head, Bausch + Lomb/International
William Humphries
Valeant Pharmaceuticals International
Group Chairman
J Pearson
Valeant Pharmaceuticals International